FRANKLIN
LAKES, N.J., July 26,
2022 /PRNewswire/ -- The Board of Directors of BD
(Becton, Dickinson and Company) (NYSE: BDX) has declared a
quarterly dividend of $0.87 per
common share, payable on September 30,
2022 to holders of record on September 9, 2022. The indicated annual dividend
rate is $3.48 per share.
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health by improving medical discovery, diagnostics and the delivery
of care. The company supports the heroes on the frontlines of
health care by developing innovative technology, services and
solutions that help advance both clinical therapy for patients and
clinical process for health care providers. BD and its 75,000
employees have a passion and commitment to help enhance the safety
and efficiency of clinicians' care delivery process, enable
laboratory scientists to accurately detect disease and advance
researchers' capabilities to develop the next generation of
diagnostics and therapeutics. BD has a presence in virtually every
country and partners with organizations around the world to address
some of the most challenging global health issues. By working in
close collaboration with customers, BD can help enhance outcomes,
lower costs, increase efficiencies, improve safety and expand
access to health care. For more information on BD, please visit
bd.com or connect with us on LinkedIn at
www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Contacts:
|
|
Media:
Investors:
|
Troy Kirkpatrick
Francesca
DeMartino
|
VP, Public
Relations
SVP, Head of Investor Relations
|
858.617.2361
201.847.5743
|
troy.kirkpatrick@bd.com
francesca.demartino@bd.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bd-board-declares-dividend-301593712.html
SOURCE BD (Becton, Dickinson and Company)